ReVision Implant

Country:
Belgium
Founding year:
2020

ReVision Implant develops an implantable cortical visual prosthesis designed to bypass damaged eyes and deliver visual information directly to the brain. The company is positioned in neuroprosthetics at the intersection of neural implants, stimulation, and visual-system neuroscience.

The system combines an external visual sensor with processing electronics and an implanted microelectrode array placed at or within the visual cortex. Visual scenes are transformed into stimulation patterns using encoding and stimulation algorithms intended to elicit structured phosphene-based perception.

Primary use cases target people with profound blindness where retinal or optic-nerve pathways are not functional or cannot be addressed with retinal implants. The company is positioned for regulated clinical development, with collaborations and study planning oriented toward first-in-human evaluation and clinical translation.

Brain-Computer Interface
Assistive Technology
Experimental

Neurofounders Insights

Modality:
Visual prosthesis
Form Factor:
Implant
Interface Depth:
Implantable
Indication:
Vision
Target user:
Patients
Regulatory stage:
Investigational

Series A

ReVision Implant is developing a cortical visual prosthesis for vision restoration, placing it in a small but high-impact category of assistive neurotechnology. Its implantable approach offers potentially stronger performance than external aids, but with all the complexity of invasive translation.

Related companies

Articles featuring

ReVision Implant

No articles yet!

Press releases

No press releases published yet.